Product Information

METHYLPHENIDATE 10 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.1497 per EA under NDC 10702010101. Its NADAC has been published 470 times since Nov 15, 2017.

FDA first approved this application on May 11, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE 10 MG TABLET

Methylphenidate Hydrochloride
$0.1497per EA
DEA Schedule CII

Strength

10 mg/1

Manufacturer

KVK-Tech Inc.

NDC

10702010101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206932

FDA Approved

5/11/2017

TE Code

AB

On Market Since

5/11/2017

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE 10 MG TABLET has been published 470 times since Nov 15, 2017, and over the history we have for it it has declined 68.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1497 per EA
All-time high$0.4701 (Nov 15, 2017)
All-time low$0.1160 (Jul 17, 2024)
52-week high$0.1890
52-week low$0.1497
Median price$0.1720
Average price$0.1854
Largest weekly change+56.9% (Aug 21, 2024)
Weeks tracked470
Tracking sinceNov 15, 2017

Price History

1W

0.0%

1M

-5.2%

3M

-11.3%

6M

-8.2%

1Y

-19.0%

3Y

-0.2%

5Y

-5.5%

All

-68.2%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 10 MG TABLET, manufactured by KVK-Tech Inc., is $0.1497 per EA (NDC 10702010101), effective Nov 11, 2026.

How has the price of METHYLPHENIDATE 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE 10 MG TABLET has declined 68.2%. It has been tracked across 470 weekly CMS publications since Nov 15, 2017.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 10 MG TABLET?

Since Nov 15, 2017, the NADAC for METHYLPHENIDATE 10 MG TABLET has ranged from a low of $0.1160 (Jul 17, 2024) to a high of $0.4701 (Nov 15, 2017), with a median of $0.1720 per EA.

Are there cheaper alternatives to METHYLPHENIDATE 10 MG TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE 10 MG TABLET, is $0.1374 per EA — about 8% below METHYLPHENIDATE 10 MG TABLET.

Who manufactures METHYLPHENIDATE 10 MG TABLET?

METHYLPHENIDATE 10 MG TABLET (NDC 10702010101) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.